The association of Diabetes Mellitus with Amyloid and Tau biomarkers
Stephan Duijkers, Jolien van der Velden, Veerle van Gils, Julie Elisabeth Oomens, Stephanie J B Vos, Inez HGB Ramakers, Pieter Jelle Visser, Willemijn J Jansen, the Amyloid Biomarker Study group · 2025
Read The association of Diabetes Mellitus with Amyloid and Tau biomarkers by Stephan Duijkers, Jolien van der Velden, Veerle van Gils, Julie Elisabeth Oomens, Stephanie J B Vos, Inez HGB Ramakers, Pieter Jelle Visser, Willemijn J Jansen, the Amyloid Biomarker Study group (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11716470.txt.
Description
Stephan Duijkers and co-authors test whether diabetes links to the brain proteins that mark Alzheimer's disease, in a 2025 paper. Diabetes raises the risk of Alzheimer's dementia. Whether it changes the underlying amyloid and tau pathology was unclear. Those proteins can be measured in spinal fluid. Their pattern defines the disease's biological stage.
The study pooled thousands of participants with normal thinking or mild impairment. Diabetes status was compared with amyloid and tau profiles. The analysis separated effects in each thinking group. A firm link would suggest diabetes feeds the core pathology. A weak one would point to other routes, such as vessel damage. The answer shapes prevention trials for diabetic patients.
Catalog record
| CREATOR | Stephan Duijkers, Jolien van der Velden, Veerle van Gils, Julie Elisabeth Oomens, Stephanie J B Vos, Inez HGB Ramakers, Pieter Jelle Visser, Willemijn J Jansen, the Amyloid Biomarker Study group |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |